While several founder GPVs in classic CRC genes are well known in the Ashkenazi population, there is little information in the AJ regarding potentially pathogenic variants in cancer susceptibility genes more recently described in the general population (e.g. POLE, POLD1, and NTHL1). This evidence concerns the gene POLD1 and colorectal carcinoma.